An increasing number of women reports unplanned pregnancies while using popular weight loss drugs such as Ozempic, Wegovy and Mounjaro-a serious public health warning in the United Kingdom.
The Medicines and Health Care Regulatory Organization (MHRA) issued the first public warning about the relationship between weight loss and contraception drugs. The warning follows 40 reports related to pregnancy associated with these drugs, which work by imitating bowel hormones that suppress appetite and slow digestion.
OZEMPIC and Wegovy contain both semiglutide, while the Mounjaro contains tizepatide and Saxenda contains Liraglutide. Although it is often referred to as “weight loss injections”, they have not been officially approved for weight management. Some, such as OZEMPIC, were developed to treat type 2 diabetes, but have gained attraction for slimming results.
These drugs slow down the digestive process, helping people feel complete and eat less. But this slower digestion can also interfere with how oral contraceptives are absorbed into the body – especially with the tizzattis, the active ingredient in the Mounjaro.
According to MHRA, Mounjaro can reduce the effectiveness of oral contraceptives in people with higher BMIS. Of the 40 cases related to the pregnancy reported, 26 were associated with Mounjaro, while 8 were semaglutide (Ozempic/Wegovy) and 9 that included Liraglutide (Saxenda). Two reports specifically indicate that the pregnancies were unintentional.
Because weight loss can lead to a surprise pregnancy
There are two main reasons why pregnancy rates are increasing between users of these drugs:
- Restored fertility due to weight loss
Weight loss can improve ovulation and fertility on its own. Dr. Channa Jayasena, a consultant in reproductive endocrinology, explained that women with obesity losing weight using GLP? - Interference with birth control
GLP; 1 drugs such as Mounjaro Slow Gastric Empling, which can lead to reduced pill absorption, especially at starting the drug or changing doses. This makes typical birth control pills less reliable without a backup method.
In response, MHRA now advises that:
Women using Mounjaro and oral contraceptives should add a barrier method, such as condoms, for at least 4 weeks after starting or increasing dose.
Those who plan to become pregnant should stop the drugs much earlier:
- Semaglutide (ozempic/wegovy): wait at least 2 months before you try to capture.
- Tirzepatide (Mounjaro): Wait 1 month after interruption.
- Liraglutide (SAXENDA): Stop before attempting pregnancy.
These drugs should not be taken during pregnancy while trying to become pregnant or while breastfeeding due to lack of safety data.
Dr. Alison Cave, the head of MHRA Security, He stressed that these medicines are not cosmetic treatments and are approved only for specific medical uses. “It’s not a quick solution,” he said. “They have not been assessed for security when used as a way to lose weight for the sake of appearance.”
A quick search for Facebook for “Ozempic Babies” finds dozens of women who share amazing pregnancy stories after taking drug loss. Many believed that they were protected from birth control or alleged pregnancy was unlikely due to previous fertility issues, only to find out later that they were expecting.
These first -hand accounts add concerns between healthcare professionals who say that, as more people use these medicines, raising awareness of their impact on fertility and contraception should also develop.
Dr. Jayasena notes that while we still do not know how harmful these medicines can be during pregnancy, it is best to be careful. “Other forms of weight loss, such as bariatric surgery, have been linked to an increased risk of miscarriage,” he explained. “So women are recommended to do everything they can to prevent pregnancy while taking GLP? 1 medicine.”
Professor Ying Cheong, a reproductive medicine specialist, agrees. He told the Guardian that more public education is required: “Weight loss improves fertility and drugs that delay gastric discharge can also delay or reduce contraceptive efficacy.
Bottom line for women using GLP drugs? 1
If you get Ozempic, Wegovy, Mounjaro or Saxenda, and you are not actively trying to capture:
- Use reliable contraception – and consider adding a barrier method, especially with Mounjaro.
- Discuss with the healthcare provider about a plan to control reserve births.
- Do not assume that you are barren due to previous weight problems.
- Stop the drug much earlier if you plan to become pregnant.
- Never use GLP medicines? 1 during pregnancy or while breastfeeding.
While these medicines prove to be effective tools for weight management and type 2 diabetes, they are not without risk – especially when it comes to reproductive health. This new guidance by MHRA is a reminder that even “miracles” require close medical supervision and clear communication on family planning.
Pregnancy Package
This post includes subsidiaries where we will receive a small percentage if you buy through the link.
